Prescription drug spending between 2014 and 2015 increased at a much higher rate among health exchange plans compared with commercial plans, Medicare, and Medicaid plans. Express Scripts highlighted 3 select trends that are having the biggest impact on plans.
Express Scripts’ most recent (June 2016) Exchange Pulse Report presents 2 years of the company’s data and trend tracking that reflect its experience as a pharmacy benefit manager for a third of the more than 9 million Americans enrolled in an insurnace exchange benefit in 2015.
The Exchange Pulse Report focuses on 3 select trends that are having the biggest impact on plans and tracks year-over-year increases and decreases in pharmacy utilization and cost. The 3 insights highlighted in the report are those that the company believes health plans need to understand to ensure they continue to offer an affordable and meaningful benefit and be ready for any new challenges presented by the changing healthcare environment.
Prescription drug spending between 2014 and 2015 increased at a much higher rate among health exchange plans compared with commercial plans, Medicare, and Medicaid plans. An important factor to consider is that many enrollees in the public exchange plans had never had a drug benefit before, and many enrollees are seeking treatment for pre-existing and newly diagnosed conditions and are still only beginning to fully understand and take advantage of their benefits. The 3 trends the report highlights are:
The report also made several recommendations for plans to prepare for the near future.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More